Cart
sales@molnova.com
MRT68921 HCl
CAS No. 2070014-87-6
MRT68921 HCl( —— )
Catalog No. M20090 CAS No. 2070014-87-6
MRT68921 hydrochloride is a potent inhibitor of both ULK1 and ULK2 (IC50s: 2.9 and 1.1 nM respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 58 | In Stock |
|
| 5MG | 57 | In Stock |
|
| 10MG | 90 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 333 | In Stock |
|
| 100MG | 415 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMRT68921 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionMRT68921 hydrochloride is a potent inhibitor of both ULK1 and ULK2 (IC50s: 2.9 and 1.1 nM respectively).
-
DescriptionMRT68921 hydrochloride is a potent inhibitor of both ULK1 and ULK2 (IC50s: 2.9 and 1.1 nM respectively).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorULK1| ULK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2070014-87-6
-
Formula Weight471.04
-
Molecular FormulaC25H34N6O·HCl
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mg/mL;Water: 10 mg/mL
-
SMILESCl.CN1CCc2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)ccc2C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Petherick KJ et al. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015 May 1;290(18):11376-83.
molnova catalog
related products
-
EACC
EACC selectively inhibits the translocation of autophagosome-specific SNARE Stx17 thereby blocking autophagosome-lysosome fusion.?
-
SJFα
SJFα (SJF alpha) is a PROTAC formed by an E3 ubiquitin ligase-conjugated protein hydrolysis regulator that degrades p38α and p38δ and can be used in cancer research.
-
STF-62247
STF-62247 is a small molecule Autophagy inducer that induces autophagy and selectively induces lethality in VHL-deficient RCC cells.
